CLS Holdings USA (CLSH) Stock Price, News & Analysis

Company Overview

CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, that includes oils, waxes, edibles, and shatters; and provides toll processing services. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. It offers its products under Oasis Cannabis and City Trees brand names. The company's concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Vegas, Nevada.

Key Stats

• Today's Range: $0.03 to $0.04
• 50-Day Range: $0.03 to $0.06
• 52-Week Range: $0.02 to $0.07
• Volume: 338,296 shs
• Average Volume: 73,488 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLSH Stock Analysis - Frequently Asked Questions

How have CLSH shares performed this year?

CLS Holdings USA's stock was trading at $0.0425 at the start of the year. Since then, CLSH stock has decreased by 25.9% and is now trading at $0.0315.
View the best growth stocks for 2024 here.

How do I buy shares of CLS Holdings USA?

Shares of CLSH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of CLS Holdings USA own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CLS Holdings USA investors own include Fulcrum Therapeutics (FULC), KushCo (KSHB), VIVUS (VVUS), iAnthus Capital (ITHUF), Aurora Cannabis (ACB), Organigram (OGI) and Processa Pharmaceuticals (PCSA).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Retail
• Current Symbol: OTCMKTS:CLSH
• CUSIP: N/A
• CIK: 1522222
• Web: www.clsholdingsinc.com
• Phone: (416) 992-4539
• Fax: N/A
• Employees: 75
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A